TGA update: Special Access Scheme (SAS)

The Therapeutic Goods Administration (TGA) has recently changed the pathways for prescribers accessing unapproved medicines under the SAS. What is the SAS? The Special Access Scheme (SAS) allows a medication that is unapproved by the TGA to be imported and supplied for a single patient on a case by case basis. What is an unapproved … Continued

Medicines Information – Intravenous Amoxicillin + Clavulanic Acid

INTRAVENOUS  amoxicillin + clavulanic acid has been added to the RCH formulary and can be used with consultant approval. Dosing of  intravenous amoxicillin + clavulanic acid is now available within the AMH Children’s Dosing Companion. Administration of  intravenous amoxicillin + clavulanic acid is now available in the RCH The Paediatric Injectable Guidelines  

Medicines Information: Piperacillin/Tazobactam Torsades de Pointes Risk        

Piperacillin/Tazobactam has been added to the CredibleMeds® list of drugs with a Conditional Risk* of causing torsades de pointes (TdP). Piperacillin/tazobactam may cause hypokalaemia, which presents a risk of TdP.   *Drugs with Conditional Risk of TdP: Substantial evidence supports the conclusion that these drugs prolong QT and have a risk of developing TdP but only … Continued

Product Recall: Lucrin Depot PDS 30 mg

Abbvie Pty Ltd the manufacturer of Lucrin Depot in consultation with the Therapeutic Goods Administration has issued a recall of the following batch of Lucrin Depot Paediatric 30 mg PDS  Batch number 1078155 Expiry 10/2019 The above batch was not dissolving prior to injection and visibly clumping, possibly delivering a sub-therapeutic dose. All other batches of … Continued

Product Recall: Gentamicin Injection BP 80 mg in 2 mL Steriluer® Ampoules

The Therapeutic Goods Administration (TGA) in conjunction with Pfizer, the manufacturer of Gentamicin Injection BP 80 mg in 2 mL Steriluer® ampoules issued a recall for multiple batches in early October 2017. Some ampoules may contain higher than expected amounts of histamine, an usual constituent in the final product. Histamine injected via intravenous or intramuscular injection … Continued

Product Recall: Heparin 5000 units/5mL AND Lignocaine 50 mg/5 mL

Pfizer, in consultation with the Therapeutic Goods Administration (TGA), is undertaking urgent recalls involving both Heparin 5000 Units/5 mL injection ampoules and Lignocaine 50 mg/5 mL injection ampoules as some packages may contain the incorrect product. Details of both recalls and the batches involved can be found in the links below. Heparin Batch A473 – expiry … Continued

Pharmacy Five: Leith Lilley – Pharmacy Business and Development Manager

1. Who are you and what is your role? My name is Leith Lilley and I am the RCH Pharmacy’s Business and Development Manager. I manage the Pharmacy Business Unit which undertakes projects that enhance paediatric health care. This involves managing the manufacture of specialist paediatric therapeutic products, such as HyperSal6 and Nappy Goo, as … Continued